Corbus Pharmaceuticals Holdings, Inc. (CRBP)
4.05
-0.08
(-1.94%)
USD |
NASDAQ |
Oct 23, 16:00
4.04
-0.01
(-0.25%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Market Cap : 75.62M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 75.62M |
| October 22, 2026 | 77.11M |
| October 21, 2026 | 80.01M |
| October 20, 2026 | 82.53M |
| October 19, 2026 | 83.27M |
| October 16, 2026 | 84.40M |
| October 15, 2026 | 80.85M |
| October 14, 2026 | 82.34M |
| October 13, 2026 | 89.25M |
| October 12, 2026 | 98.40M |
| October 09, 2026 | 100.45M |
| October 08, 2026 | 98.40M |
| October 07, 2026 | 102.51M |
| October 06, 2026 | 107.92M |
| October 05, 2026 | 109.23M |
| October 02, 2026 | 114.46M |
| October 01, 2026 | 118.38M |
| September 30, 2026 | 127.34M |
| September 29, 2026 | 123.79M |
| September 28, 2026 | 129.21M |
| September 25, 2026 | 133.31M |
| September 24, 2026 | 139.10M |
| September 23, 2026 | 144.52M |
| September 22, 2026 | 147.04M |
| September 21, 2026 | 142.84M |
| Date | Value |
|---|---|
| September 18, 2026 | 139.66M |
| September 17, 2026 | 135.56M |
| September 16, 2026 | 135.56M |
| September 15, 2026 | 129.21M |
| September 14, 2026 | 150.87M |
| September 11, 2026 | 151.61M |
| September 10, 2026 | 153.85M |
| September 09, 2026 | 165.43M |
| September 08, 2026 | 197.82M |
| September 04, 2026 | 206.88M |
| September 03, 2026 | 213.98M |
| September 02, 2026 | 214.35M |
| September 01, 2026 | 210.61M |
| August 31, 2026 | 203.71M |
| August 28, 2026 | 203.71M |
| August 27, 2026 | 207.81M |
| August 26, 2026 | 210.99M |
| August 25, 2026 | 211.17M |
| August 24, 2026 | 199.60M |
| August 21, 2026 | 193.81M |
| August 20, 2026 | 183.73M |
| August 19, 2026 | 186.53M |
| August 18, 2026 | 188.21M |
| August 17, 2026 | 195.86M |
| August 14, 2026 | 188.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| PEG Ratio | -0.0221 |
| Price to Book Value | 0.7396 |
| Price | 4.05 |
| Earnings Yield | -152.5% |
| PEGY Ratio | -0.0221 |